Private equity firm GTCR’s portfolio company Regatta Medical said today it acquired a majority stake in Resonetics, with its current team led by CEO Tom Burns slated to continue their roles with the company.
The deal, which included an increased investment from previous owner Sverica, is slated to close sometime in early February, Boston-based Sverica said.
Disclosure: Resonetics is a customer of WTWH Media.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.